Background: Adhesions due to pelvic/abdominal surgery are a common serious pathology possibly entailing severe complications. This study investigates the adhesion prevention capability of the novel starch-based agent 4DryField® PH, which together with saline solution forms a barrier gel. Herein, an optimized adhesion model (OPAM) inducing severe adhesions/agglutinations with high reproducibility was used. Methods: In 19 Lewis rats, a 1 × 2 cm abdominal wall defect was created, the peritoneum of the neighboring cecum was abraded, and both injured areas were approximated by suture. Rats were randomized to control (n = 10) or 4DryField PH treatment (n = 9) groups. Another 8 rats had sham surgery for safety assessment of 4DryField PH. At day 7, the quantity and quality of adhesions were assessed macro-/microscopically and evaluated statistically. Results: 4DryField PH treatment significantly reduced the incidence and severity of adhesions as verified by significantly improved adhesion scorings (0.4 vs. 4.5; 1.1 vs. 9). Histology revealed reconstitution of the cecum and abdominal wall including regeneration of the visceral/parietal peritoneum. In sham-operated rats, 4DryField PH did not induce adhesion formation. Conclusions: 4DryField PH gel was highly effective in preventing adhesions. Histologically, the injured cecum and abdominal wall regenerated well in the presence of 4DryField PH. Considering the severity of OPAM trauma, the potential of 4DryField PH to prevent adhesions can be rated excellent.

Keywords:
Optimized adhesion formation model, Modified polysaccharide, 4DryField® PH, Abdominal surgery, Adhesion prevention barrier
1.
Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D, McGuire A, Lower AM, Hawthorn RJ, O'Brien F, Buchan S, Crowe AM: Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 1999;353:1476-1480.
2.
Kamel RM: Prevention of postoperative peritoneal adhesions. Eur J Obstet Gynecol Reprod Biol 2010;150:111-118.
3.
Hellebrekers BW, Kooistra T: Pathogenesis of postoperative adhesion formation. Br J Surg 2011;98:1503-1516.
4.
Menzies D, Ellis H: Intestinal obstruction from adhesions - how big is the problem? Ann R Coll Surg Engl 1990;72:60-63.
5.
diZerega GS: Contemporary adhesion prevention. Fertil Steril 1994;61:219-235.
6.
Cates W, Farley TM, Rowe PJ: Worldwide patterns of infertility: is Africa different? Lancet 1985;2:596-598.
7.
Trimbos-Kemper TC, Trimbos JB, van Hall EV: Adhesion formation after tubal surgery: results of the eighth-day laparoscopy in 188 patients. Fertil Steril 1985;43:395-400.
8.
Nieuwenhuijzen M, Reijnen MM, Kuijpers JH, van Goor H: Small bowel obstruction after total or subtotal colectomy: a 10-year retrospective review. Br J Surg 1998;85:1242-1245.
9.
Vrijland WW, Jeekel J, van Geldorp HJ, Swank DJ, Bonjer HJ: Abdominal adhesions: intestinal obstruction, pain, and infertility. Surg Endosc 2003;17:1017-1022.
10.
Vrijland WW, Jeekel J: Prosthetic mesh repair should be used for any defect in the abdominal wall. Curr Med Res Opin 2003;19:1-3.
11.
Hirschelmann A, Tchartchian G, Wallwiener M, Hackethal A, De Wilde RL: A review of the problematic adhesion prophylaxis in gynaecological surgery. Arch Gynecol Obstet 2012;285:1089-1097.
12.
Holmdahl L, Risberg B: Adhesions: prevention and complications in general surgery. Eur J Surg 1997;163:169-174.
13.
Larsson B, Nisell H, Granberg I: Surgicel - an absorbable hemostatic material - in prevention of peritoneal adhesions in rats. Acta Chir Scand 1978;144:375-378.
14.
Larsson B, Svanberg SG, Swolin K: Oxyphenbutazone - an adjuvant to be used in prevention of adhesions in operations for fertility. Fertil Steril 1977;28:807-808.
15.
Galan N, Leader A, Malkinson T, Taylor PJ: Adhesion prophylaxis in rabbits with surgicel and two absorbable microsurgical sutures. J Reprod Med 1983;28:662-664.
16.
Lindenberg S, Lauritsen JG: Prevention of peritoneal adhesion formation by fibrin sealant. An experimental study in rats. Ann Chir Gynaecol 1984;73:11-13.
17.
Lindenberg S, Steentoft P, Sorensen SS, Olesen HP: Studies on prevention of intra-abdominal adhesion formation by fibrin sealant. An experimental study in rats. Acta Chir Scand 1985;151:525-527.
18.
Novitsky YW, Harrell AG, Cristiano JA, Paton BL, Norton HJ, Peindl RD, Kercher KW, Heniford BT: Comparative evaluation of adhesion formation, strength of ingrowth, and textile properties of prosthetic meshes after long-term intra-abdominal implantation in a rabbit. J Surg Res 2007;140:6-11.
19.
Kavic SM, Kavic SM, Kavic MS: Adhesions and adhesiolysis; in Kavic MS, Nezhat C, Winfield H (eds): Prevention and Management of Laparoendoscopic Surgical Complications, ed 3. JSLS Publications, 2010.
20.
Lauder CI, Garcea G, Strickland A, Maddern GJ: Use of a modified chitosan-dextran gel to prevent peritoneal adhesions in a rat model. J Surg Res 2011;171:877-882.
21.
Poehnert D, Abbas M, Kreipe HH, Klempnauer J, Winny M: High reproducibility of adhesion formation in rat with meso-stitch approximation of injured cecum and abdominal wall. Int J Med Sci 2015;12:1-6.
22.
Harris ES, Morgan RF, Rodeheaver GT: Analysis of the kinetics of peritoneal adhesion formation in the rat and evaluation of potential antiadhesive agents. Surgery 1995;117:663-669.
23.
Hoffmann NE, Siddiqui SA, Agarwal S, McKellar SH, Kurtz HJ, Gettman MT, Ereth MH: Choice of hemostatic agent influences adhesion formation in a rat cecal adhesion model. J Surg Res 2009;155:77-81.
24.
Dunn R, Lyman MD, Edelman PG, Campbell PK: Evaluation of the SprayGel adhesion barrier in the rat cecum abrasion and rabbit uterine horn adhesion models. Fertil Steril 2001;75:411-416.
25.
Dilege E, Coskun H, Gunduz B, Sakiz D, Mihmanli M: Prevention of adhesion to prosthetic mesh in incisional ventral hernias: comparison of different barriers in an experimental model. Eur Surg Res 2006;38:358-364.
26.
Lalountas M, Ballas KD, Michalakis A, Psarras K, Asteriou C, Giakoustidis DE, Nikolaidou C, Venizelos I, Pavlidis TE, Sakantamis AK: Postoperative adhesion prevention using a statin-containing cellulose film in an experimental model. Br J Surg 2012;99:423-429.
27.
Shimizu A, Suhara T, Ito T, Omichi K, Naruse K, Hasegawa K, Kokudo N: New hepatectomy-induced postoperative adhesion model in rats, and evaluation of the efficacy of anti-adhesion materials. Surg Today 2014;44:314-323.
28.
Muller SA, Treutner KH, Haase G, Kinzel S, Tietze L, Schumpelick V: Effect of intraperitoneal antiadhesive fluids in a rat peritonitis model. Arch Surg 2003;138:286-290.
29.
Wallwiener M, Brucker S, Hierlemann H, Brochhausen C, Solomayer E, Wallwiener C: Innovative barriers for peritoneal adhesion prevention: liquid or solid? A rat uterine horn model. Fertil Steril 2006;86:1266-1276.
30.
Degenhardt P, Pelzer M, Fischer B, Kraft S, Sarioglu N, Mau H, Rudiger M: Reduction of postoperative adhesions by perfluorocarbons: an experimental study in a rat model. Eur J Pediatr Surg 2009;19:211-215.
31.
Rajab TK, Wallwiener M, Planck C, Brochhausen C, Kraemer B, Wallwiener CW: A direct comparison of Seprafilm, Adept, Intercoat, and Spraygel for adhesion prophylaxis. J Surg Res 2010;161:246-249.
32.
Ditzel M, Deerenberg EB, Komen N, Mulder IM, Jeekel H, Lange JF: Postoperative adhesion prevention with a new barrier: an experimental study. Eur Surg Res 2012;48:187-193.
33.
Yigitler C, Karakas DO, Kucukodaci Z, Cosar A, Gulec B, Akin ML: Adhesion-preventing properties of 4% icodextrin and canola oil: a comparative experimental study. Clinics (Sao Paulo) 2012;67:1303-1308.
34.
Yoldemir T, Sagol S, Adakan S, Oztekin K, Ozsener S, Karadadas N: Comparison of the reduction of postoperative adhesions by two barriers, one solution, and two pharmacologic agents in the rat uterine model. Fertil Steril 2002;78:335-339.
35.
Temiz A, Ozturk C, Bakunov A, Kara K, Kaleli T: A new material for prevention of peritendinous fibrotic adhesions after tendon repair: oxidised regenerated cellulose (Interceed), an absorbable adhesion barrier. Int Orthop 2008;32:389-394.
36.
Cho WJ, Oh SH, Lee JH: Alginate film as a novel post-surgical tissue adhesion barrier. J Biomater Sci Polym Ed 2010;21:701-713.
37.
Peyton CC, Keys T, Tomblyn S, Burmeister D, Beumer JH, Holleran JL, Sirintrapun J, Washburn S, Hodges SJ: Halofuginone infused keratin hydrogel attenuates adhesions in a rodent cecal abrasion model. J Surg Res 2012;178:545-552.
38.
Takagi K, Araki M, Fukuoka H, Takeshita H, Hidaka S, Nanashima A, Sawai T, Nagayasu T, Hyon SH, Nakajima N: Novel powdered anti-adhesion material: preventing postoperative intra-abdominal adhesions in a rat model. Int J Med Sci 2013;10:467-474.
39.
Takagi K, Tsuchiya T, Araki M, Yamasaki N, Nagayasu T, Hyon SH, Nakajima N: Novel biodegradable powder for preventing postoperative pleural adhesion. J Surg Res 2013;179:e13-e19.
40.
Hellebrekers BW, Trimbos-Kemper GC, van Blitterswijk CA, Bakkum EA, Trimbos JB: Effects of five different barrier materials on postsurgical adhesion formation in the rat. Hum Reprod 2000;15:1358-1363.
41.
Erpek H, Tuncyurek P, Soyder A, Boylu S: Hyaluronic acid/carboxymethylcellulose membrane barrier versus taurolidine for the prevention of adhesions to polypropylene mesh. Eur Surg Res 2006;38:414-417.
42.
Irkorucu O, Ferahkose Z, Memis L, Ekinci O, Akin M: Reduction of postsurgical adhesions in a rat model: a comparative study. Clinics (Sao Paulo) 2009;64:143-148.
43.
Kaptanoglu L, Kucuk HF, Yegenoglu A, Uzun H, Eser M, Mentes CV, Kurt N: Effects of seprafilm and heparin in combination on intra-abdominal adhesions. Eur Surg Res 2008;41:203-207.
44.
Dietrich A, Bouzidi M, Hartwig T, Schutz A, Jonas S: Rapamycin and a hyaluronic acid-carboxymethylcellulose membrane did not lead to reduced adhesion formations in a rat abdominal adhesion model. Arch Gynecol Obstet 2012;285:1603-1609.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.